ReviewJournal of personalized medicine2023

Immunotherapy Targeting PD-1/PD-L1 in Early-Stage Triple-Negative Breast Cancer.

Tinglin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.